Harry J. de Koning

Also affiliated with Erasmus University Rotterdam

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.903Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database

BMJ Open Respiratory Research(2020)10.1136/bmjresp-2020-000603

Top 22%

0.903DataRank

Top 22%13 citations

Kevin ten Haaf, Douglas A. Arenberg, Harry J. de Koning, Erik F. Blom

Papers

Driven by 20 papers — median percentile 78. Top paper: “Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam”.

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam

JNCI: Journal of the National Cancer Institute(2010)10.1093/jnci/djp533

N/A

3.8DataRank · unranked

49 citations

Gerrit Draisma, Eveline A. M. Heijnsdijk, Monique J. Roobol, Rob Boer, Suzie J. Otto +2 more

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue

New England Journal of Medicine(2019)10.1056/nejmoa1903986

N/A

0.984DataRank · unranked

706 citations

Stéphanie V. de Lange, Ruud M. Pijnappel, Ritse M. Mann, Petra H.M. Peeters, Evelyn M. Monninkhof +15 more

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database

BMJ Open Respiratory Research(2020)10.1136/bmjresp-2020-000603

Top 22%

0.903DataRank

Top 22%13 citations

Kevin ten Haaf, Douglas A. Arenberg, Harry J. de Koning, Erik F. Blom

Quantification of coronary artery calcium in nongated CT to predict cardiovascular events in male lung cancer screening participants: Results of the NELSON study

Journal of Cardiovascular Computed Tomography(2015)10.1016/j.jcct.2014.11.006

N/A

0.650DataRank · unranked

75 citations

Ivana Išgum, Martin J. Willemink, Yolanda van der Graaf, Harry J. de Koning, Rozemarijn Vliegenthart +4 more

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa127

N/A

0.648DataRank · unranked

74 citations

Clyde B. Schechter, Nicolien T. van Ravesteyn, A. Cecile J.W. Janssens, Michael Wolfson, Amy Trentham‐Dietz +6 more

Risk Model–Based Lung Cancer Screening

Annals of Internal Medicine(2023)10.7326/m22-2216

N/A

0.631DataRank · unranked

66 citations

Pianpian Cao, Koen de Nijs, Mehrad Bastani, Vidit Munshi, Mehdi Hemmati +11 more

Digital mammography screening: Weighing reduced mortality against increased overdiagnosis

Preventive Medicine(2011)10.1016/j.ypmed.2011.06.009

N/A

0.604DataRank · unranked

55 citations

Jacques Fracheboud, Eveline A.M. Heijnsdijk, Gerard den Heeten, André L.M. Verbeek, Mireille J.M. Broeders +3 more

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies

JAMA(2024)10.1001/jama.2023.24766

N/A

0.598DataRank · unranked

53 citations

Christina Chapman, Jinani Jayasekera, Kathryn P. Lowry, Brandy M. Heckman‐Stoddard, John M. Hampton +30 more

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

Cancer Medicine(2020)10.1002/cam4.3395

N/A

0.500DataRank · unranked

27 citations

Eveline A.M. Heijnsdijk, Monique J. Roobol, Harry J. de Koning, Abraham M. Getaneh

Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screening

BMJ Open(2025)10.1136/bmjopen-2024-085118

N/A

0.104DataRank · unranked

1 citations

Samantha L. Quaife, Christine D. Berg, Matthew Callister, Philip Crosbie, Michael P.A. Davies +10 more

Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.23044

N/A

0DataRank · unranked

5 citations

Harry J. de Koning, Pianpian Cao, Maikol Diasparra, Rochelle Garner, Jihyoun Jeon +4 more

Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network

Journal of Breast Imaging(2025)10.1093/jbi/wbaf003

N/A

0DataRank · unranked

3 citations

Jennifer L. Caswell‐Jin, Harry J. de Koning, Hui Huang, Xuelin Huang, Sandra J. Lee +10 more

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration

PLoS ONE(2021)10.1371/journal.pone.0253893

N/A

0DataRank · unranked

7 citations

Iris Lansdorp‐Vogelaar, Harry J. de Koning, Reinier G.S. Meester, Amir‐Houshang Omidvari

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djaa218

N/A

0DataRank · unranked

24 citations

Clyde B. Schechter, John M. Hampton, Oğuzhan Alagöz, Jeroen J. van den Broek, Karla Kerlikowske +8 more

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs

Cancers(2022)10.3390/cancers14122951

N/A

0DataRank · unranked

18 citations

Nicolien T. van Ravesteyn, Jeroen J. van den Broek, Harry J. de Koning, Esmée K. J. van der Poort

Modeling the natural history of ductal carcinoma in situ based on population data

Breast Cancer Research(2020)10.1186/s13058-020-01287-6

N/A

0DataRank · unranked

45 citations

Nicolien T. van Ravesteyn, Xiaoxue Li, Hui Huang, Harald Weedon‐Fekjær, Marc D. Ryser +6 more

Assessing the impact of increasing lung screening eligibility by relaxing the maximum years‐since‐quit threshold: A simulation modeling study

Cancer(2023)10.1002/cncr.34925

N/A

0DataRank · unranked

24 citations

Pianpian Cao, Koen de Nijs, Jihyoun Jeon, Robert A. Smith, Kevin ten Haaf +2 more

Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density

JAMA Internal Medicine(2024)10.1001/jamainternmed.2024.4224

N/A

0DataRank · unranked

26 citations

Diana L. Miglioretti, Yu‐Ru Su, Christoph I. Lee, Linn Abraham, Oğuzhan Alagöz +15 more

The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations

Medical Decision Making(2024)10.1177/0272989x241249182

N/A

0DataRank · unranked

7 citations

Koen de Nijs, Giulia Simoni, Andres Alban, Pianpian Cao, Zhuolu Sun +10 more

Targeted lung cancer screening in the age of immunotherapies and targeted therapies – an economic evaluation for Australia

The Lancet Regional Health - Western Pacific(2024)10.1016/j.lanwpc.2024.101241

N/A

0DataRank · unranked

5 citations

Jonathan Karnon, Harry J. de Koning, Vivienne Milch, Katrina Anderson, Jacqui Real +3 more

Harry J. de Koning

Indexed papers

Top data-sharing exemplar

Papers